SynthesisScientific reports2023

Efficacy and safety of add-on anti-CD20 monoclonal antibody to Bruton tyrosine kinase inhibitor treatment for chronic lymphocytic leukemia: a meta-analysis.

Thi Thuy Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.